Brief Hospitalization for Schizophrenia: Strategies to Improve Treatment Outcome

Schizophrenia Clinical Trial

Official title:

Brief Hospitalization for Schizophrenia: Strategies to Improve Treatment Outcome

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00018837
• Other study ID #: MHBS-010-98S
• Status: Completed
• Phase: N/A
• First received: July 3, 2001
• Last updated: January 20, 2009
• Start date: April 1998
• Est. completion date: March 2001

Study information

• Verified date: December 2004
• Source: VA Office of Research and Development
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Federal Government
• Study type: Interventional

Clinical Trial Summary

The goal of this research program is to implement a series of psychoeducational training classes designed to teach individuals with schizophrenia the importance of medication treatment, how to identify and manage medication side effects, and how to make appointments and emergency plans. The skills taught to the research subjects will lead to demonstrable increases (compared to the control group) in adherence to both the prescribed medication regimen and scheduled outpatient appointments and thereby cause a decrease (again compared to the control group) in rehospitalization rates and bed-days during subsequent twelve months following the intervention. A secondary objective of this work is that if the CREP program is successful and/or illness education is effective, the data will be able to disseminated throughout the VISN 22 via the recently awarded Mental Illness Research Education and Clinical Center (MIRECC) program.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 0
• Est. completion date: March 2001
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years to 65 Years

Eligibility

Inclusion Criteria:

1. Age 18-65 years of age.

2. DSM IV diagnosis of schizophrenia or schizoaffective disorder.

3. Competent to give informed consent.

4. Previously participated in "Brief Hospitalization for Schizophrenia: Strategies to Improve Treatment Outcome" Principal Investigator. Donna Wirshing, M.D.

Exclusion Criteria:

1. Physical or cognitive impairment of such severity as to adversely affect the validity of clinical ratings or impair capacity to give informed consent.

2. History of substantial substance dependence 6 months prior to the study.

3. Patients at high risk of suicide or other directed violence.

Study Design

Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment

Related Conditions & MeSH terms

• Schizophrenia
• Schizophrenic Disorder

Intervention

Behavioral:
• Community Re-Entry Program: What is Schizophrenia

Locations

Country	Name	City	State
United States	VA Greater Los Angeles Healthcare System	Los Angeles	California

Sponsors (1)

Lead Sponsor	Collaborator
VA Office of Research and Development

Country where clinical trial is conducted

United States,